TFA Therapeutics annual operating income
2021
2022
2023
2024
2025
TFA Therapeutics Operating Income Growth & History (RAJAF)
TFA Therapeutics's operating income was −$141,128 for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$141,128 | $42,785 | — |
| 2024 | 2024-12-31 | −$183,913 | −$411,746 | — |
| 2023 | 2023-12-31 | $227,833 | $642,954 | — |
| 2022 | 2022-12-31 | −$415,121 | −$295,734 | — |
| 2021 | 2021-12-31 | −$119,387 | — | — |
TFA Therapeutics operating income trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's operating income decreased from −$119,387 to −$141,128, a change of −$21,741.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗